Breast Cancer - Anti-Progestin Prevention Study 1
NCT02408770
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
24
Enrollment
OTHER_GOV
Sponsor class
Conditions
Breast Cancer
Interventions
DRUG:
ulipristal acetate
Sponsor
Manchester University NHS Foundation Trust
Collaborators
[object Object]